Finance

Benchmark sees surge in revenue, EBITDA as core markets improve, but net loss widens

However, the group lauded ‘excellent’ results in the first quarter across its three business segments.

'We are performing in line with market expectations for the full year, with building momentum in our commercial, operating, and financial performance in all business areas,' said Trond Williksen, CEO of the group.
'We are performing in line with market expectations for the full year, with building momentum in our commercial, operating, and financial performance in all business areas,' said Trond Williksen, CEO of the group.Photo: Robert Nedrejord
Published 22 February 2022, 09:28Updated 22 February 2022, 13:58
NorwayUnited KingdomBenchmarkTrond WilliksenGenetics